Article

STAAR Surgical names Andrews as CFO

Monrovia, CA—STAAR Surgical Co. has named Deborah Andrews as its new chief financial officer (CFO), confirming a role she has filled on an interim basis since April.

Monrovia, CA-STAAR Surgical Co. has named Deborah Andrews as its new chief financial officer (CFO), confirming a role she has filled on an interim basis since April.

Andrews, who has been part of the firm's financial reporting team for more than 10 years, took on the role as CFO following the resignation of John Bily. She previously was the company's global controller.

In a prepared statement, company President and CEO David Bailey praised Andrews, 47, for improving STAAR's financial reporting and internal controls, and implementing cost-cutting strategies that reduced costs by $1.2 million during the second quarter of 2005 compared with the first quarter of 2005.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
© 2025 MJH Life Sciences

All rights reserved.